Original research
par
Ledlie, Shaleesa et al
Date de publication
2023
Géographie
Canada
Langue de la ressource
English
Texte disponible en version intégrale
Non
Open Access / OK to Reproduce
Non
Évalué par des pairs
Yes
L’objectif
Between 2017 and 2021 in Canada, several drug shortages occurred for Kadian© (SROM-24). The purpose of this study was to evaluate the impact of these shortages on people's ability to remain on this medication.
Constatations/points à retenir
The SROM-24 shortages resulted in significant treatment disruptions across all recipients. These findings have important implications for those with few treatment alternatives, including people using SROM-24 as OAT who are at risk of adverse outcomes following treatment disruptions.
La conception ou méthodologie de recherche
In a retrospective population-based time series analysis, we evaluated the association between SROM-24 drug shortages and treatment discontinuation.
Mots clés
Substitution/OAT
Transitions in care/treatment
Barriers and enablers
Outcomes
